Azenta (AZTA) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Azenta

NasdaqGS•Healthcare•Medical Instruments & Supplies

$30.01-0.14(<0.01%)Market open

Market Cap

$1.51B

P/S

2.5x

P/B

1.0x

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

How this company scores

AverageMetricSide Score: 40/100

Strongest: Balance Sheet & Red Flags (15/25); weakest: Cash & Earnings Quality (6/25).

Profitability9/25

Growth10/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality6/25

Strengths

Interest easily coveredNet cash positionImproving marginsNo share dilution

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 2.0x5y range 1.5x – 69.4x

Currently near its 6-quarter median.

P/S · 2.5x5y range 1.6x – 66.9x

Currently below its 20-quarter median.

P/B · 1.0x5y range 0.6x – 5.8x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

FCF consistently trails net income (avg -0.7x) — earnings may be inflated by non-cash items or aggressive accounting.

Price & Volume

Market Cap $1.51B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $613.57M
Q. Revenue: $161.18M
TTM EBITDA: $-120.17M
TTM Op. Income: $-175.83M
Q. Op. Income: $-4.18M
TTM Net Income: $-122.94M
Q. Net Income: $2.46M
EPS: $0.05
Shares Out.: $45.29M

$613.57M in TTM revenue grew 1.4% YoY, reaching $161.18M last quarter. TTM EBITDA of $-120.17M and TTM operating income of $-175.83M show growth is flowing through to the bottom line. However, net income is negative at $122.94M — growth is not yet reaching the bottom line. Across the last 8 quarters, TTM revenue has risen for 3 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 44.9%
EBITDA Margin: 5.8%
Op. Margin: -2.6%
Net Margin: 1.5%

Op. margin of -2.6% is down 2.1% YoY — costs are rising relative to revenue. Net margin at 1.5% and gross margin of 44.9% show how much of each revenue dollar survives to profit. Over the past year, operating margin is down 423% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 2.5x
P/B Ratio: 1.0x

P/S of 2.5x and P/B of 1.0x.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $1.88B
Cash: $189.65M
Long-Term Debt: N/A
Book Value: $1.51B
D/E Ratio: N/A
Debt/EBITDA: 0.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $1.45M
TTM Free Cash Flow: $9.88M
FCF Margin: 1.6%
FCF / Net Income: -0.1

TTM FCF of $9.88M on $1.45M in operating cash flow. The FCF / Net Income ratio of -0.1x means the business consumes cash — it is not yet self-funding. Across the last 8 quarters, free cash flow has fallen for 4 consecutive quarters — a weakening trend.